Veeravich Jaruvongvanich1, Wasin Ahuja, Kamonkiat Wirunsawanya, Karn Wijarnpreecha, Patompong Ungprasert. 1. aDepartment of Internal Medicine, University of Hawaii, Honolulu, Hawaii bDepartment of Internal Medicine, Norwalk Hospital, Norwalk, Connecticut cDepartment of Internal Medicine, Bassett Medical Center and Columbia University College of Physicians and Surgeons, Cooperstown, New York dDepartment of Internal Medicine, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA eDepartment of Medicine, King Chulalongkorn Memorial Hospital fDepartment of Medicine, Division of Rheumatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Abstract
BACKGROUND: Hyperuricemia is a significant risk factor for nonalcoholic fatty liver disease (NAFLD). It may also have an impact on the histologic severity of NAFLD. However, data on this association are limited. We conducted this meta-analysis to investigate the relationship of serum uric acid with liver histologic severity as determined by NAFLD activity score (NAS) in patients with NAFLD. PATIENTS AND METHODS: MEDLINE and EMBASE databases were searched through August 2016 for studies that investigated the association between hyperuricemia and NAS among patients with biopsy-proven NAFLD. Pooled odds ratio and 95% confidence interval were calculated using a random-effects model (generic inverse variance method). The between-study heterogeneity of effect size was quantified using the Q statistic and I. RESULTS: Five observational studies with 777 NAFLD patients were identified. Patients with NAFLD who had hyperuricemia had a high NAS (defined as score of ≥5) significantly more often than did those without hyperuricemia with a pooled odds ratio of 2.17 (95% confidence interval: 1.51-3.12). The statistical heterogeneity was low, with I of 16% (Pheterogeneity=0.31). CONCLUSION: In patients with NAFLD, hyperuricemia is associated with a higher degree of histological liver damage. Further studies are required to establish the role of uric acid-lowering therapy among these patients.
BACKGROUND:Hyperuricemia is a significant risk factor for nonalcoholic fatty liver disease (NAFLD). It may also have an impact on the histologic severity of NAFLD. However, data on this association are limited. We conducted this meta-analysis to investigate the relationship of serum uric acid with liver histologic severity as determined by NAFLD activity score (NAS) in patients with NAFLD. PATIENTS AND METHODS: MEDLINE and EMBASE databases were searched through August 2016 for studies that investigated the association between hyperuricemia and NAS among patients with biopsy-proven NAFLD. Pooled odds ratio and 95% confidence interval were calculated using a random-effects model (generic inverse variance method). The between-study heterogeneity of effect size was quantified using the Q statistic and I. RESULTS: Five observational studies with 777 NAFLD patients were identified. Patients with NAFLD who had hyperuricemia had a high NAS (defined as score of ≥5) significantly more often than did those without hyperuricemia with a pooled odds ratio of 2.17 (95% confidence interval: 1.51-3.12). The statistical heterogeneity was low, with I of 16% (Pheterogeneity=0.31). CONCLUSION: In patients with NAFLD, hyperuricemia is associated with a higher degree of histological liver damage. Further studies are required to establish the role of uric acid-lowering therapy among these patients.
Authors: Sebastian Zenovia; Carol Stanciu; Catalin Sfarti; Ana-Maria Singeap; Camelia Cojocariu; Irina Girleanu; Mihaela Dimache; Stefan Chiriac; Cristina Maria Muzica; Robert Nastasa; Laura Huiban; Tudor Cuciureanu; Anca Trifan Journal: Diagnostics (Basel) Date: 2021-04-27
Authors: Lukas W Unger; Bernadette Forstner; Moritz Muckenhuber; Katharina Scheuba; Ernst Eigenbauer; Bernhard Scheiner; Nikolaus Pfisterer; Rafael Paternostro; Michael Trauner; Mattias Mandorfer; Thomas Reiberger Journal: Dig Dis Sci Date: 2019-12-24 Impact factor: 3.199
Authors: Thomas Jensen; Koichiro Niwa; Ichiro Hisatome; Mehmet Kanbay; Ana Andres-Hernando; Carlos A Roncal-Jimenez; Yuka Sato; Gabriela Garcia; Minoru Ohno; Miguel A Lanaspa; Richard J Johnson; Masanari Kuwabara Journal: Sci Rep Date: 2018-08-06 Impact factor: 4.379